These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25132177)

  • 1. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
    Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
    Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
    Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
    He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.
    Sinkunas T; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
    EMBO J; 2011 Apr; 30(7):1335-42. PubMed ID: 21343909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3.
    Yoshimi K; Takeshita K; Kodera N; Shibumura S; Yamauchi Y; Omatsu M; Umeda K; Kunihiro Y; Yamamoto M; Mashimo T
    Nat Commun; 2022 Aug; 13(1):4917. PubMed ID: 36042215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli.
    Hayes RP; Xiao Y; Ding F; van Erp PB; Rajashankar K; Bailey S; Wiedenheft B; Ke A
    Nature; 2016 Feb; 530(7591):499-503. PubMed ID: 26863189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas3 nuclease-helicase activity assays.
    Sinkunas T; Gasiunas G; Siksnys V
    Methods Mol Biol; 2015; 1311():277-91. PubMed ID: 25981480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex.
    Nimkar S; Anand B
    Nucleic Acids Res; 2020 Mar; 48(5):2486-2501. PubMed ID: 31980818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
    Loeff L; Brouns SJJ; Joo C
    Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Dynamics of DNA Binding and Cas3 Recruitment by the CRISPR RNA-Guided Cascade Complex.
    van Erp PBG; Patterson A; Kant R; Berry L; Golden SM; Forsman BL; Carter J; Jackson RN; Bothner B; Wiedenheft B
    ACS Chem Biol; 2018 Feb; 13(2):481-490. PubMed ID: 29035497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System.
    Xiao Y; Luo M; Hayes RP; Kim J; Ng S; Ding F; Liao M; Ke A
    Cell; 2017 Jun; 170(1):48-60.e11. PubMed ID: 28666122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
    Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
    Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly and Translocation of a CRISPR-Cas Primed Acquisition Complex.
    Dillard KE; Brown MW; Johnson NV; Xiao Y; Dolan A; Hernandez E; Dahlhauser SD; Kim Y; Myler LR; Anslyn EV; Ke A; Finkelstein IJ
    Cell; 2018 Nov; 175(4):934-946.e15. PubMed ID: 30343903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure basis for RNA-guided DNA degradation by Cascade and Cas3.
    Xiao Y; Luo M; Dolan AE; Liao M; Ke A
    Science; 2018 Jul; 361(6397):. PubMed ID: 29880725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of Thermobifida fusca Cse1 reveals target DNA binding site.
    Tay M; Liu S; Yuan YA
    Protein Sci; 2015 Feb; 24(2):236-45. PubMed ID: 25420472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution and biochemical characterization of ribonucleoprotein complexes in Type I-E CRISPR-Cas systems.
    Xiao Y; Ke A
    Methods Enzymol; 2019; 616():27-41. PubMed ID: 30691647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.
    Beloglazova N; Petit P; Flick R; Brown G; Savchenko A; Yakunin AF
    EMBO J; 2011 Oct; 30(22):4616-27. PubMed ID: 22009198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of Cas3 activation in type I-C CRISPR-Cas system.
    Kim DY; Lee SY; Ha HJ; Park HH
    Nucleic Acids Res; 2024 Sep; 52(17):10563-10574. PubMed ID: 39180405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System.
    Redding S; Sternberg SH; Marshall M; Gibb B; Bhat P; Guegler CK; Wiedenheft B; Doudna JA; Greene EC
    Cell; 2015 Nov; 163(4):854-65. PubMed ID: 26522594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.